Increased Incidence or Recurrence of Hepatocellular Carcinoma in Hepatitis C Virus Cirrhotic Patients Treated With Direct-Acting Antivirals: Myth or Fact?

Expert Review of Anticancer Therapy - United Kingdom
doi 10.1080/14737140.2018.1443814
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

The Risk of Hepatocellular Carcinoma Is Increased in Hepatitis C Virus Patients Treated With Interferonfree Direct-Acting Antiviral-Based Therapy: True or False?

Biomedical Journal of Scientific & Technical Research
2018English

Hepatitis B Reactivation in Chronic Hepatitis C Patients Treated With Interferon or Pan-Oral Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Direct-Acting Antivirals and Recurrence of Hepatocellular Carcinoma

Liver Transplantation
HepatologyTransplantationSurgery
2017English

Hepatocellular Carcinoma Decreases the Chance of Successful Hepatitis C Virus Therapy With Direct-Acting Antivirals

Journal of Hepatology
Hepatology
2017English

Unexpected Viral Relapses in Hepatitis C Virus-Infected Patients Diagnosed With Hepatocellular Carcinoma During Treatment With Direct-Acting Antivirals

Hepatology
MedicineHepatology
2017English

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals for HCV Infection

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2019English

Hepatitis C Related Hepatocellular Carcinoma in the Era of Direct-Acting Antivirals

Hepatoma Research
2018English

The Interplay Between Direct-Acting Antivirals and Hepatocellular Carcinoma in Chronic Hepatitis C

Hepatoma Research
2020English

The Risk of Early Occurrence and Recurrence of Hepatocellular Carcinoma in Hepatitis C-Infected Patients Treated With Direct-Acting Antivirals With and Without Pegylated Interferon: A Belgian Experience

Journal of Viral Hepatitis
VirologyHepatologyInfectious Diseases
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy